SeekingAlpha · Jul 8, 2026
BTX: No One Is Interested In Free Exposure To Anthropic
BlackRock Technology and Private Equity Term Trust aims for 80% tech exposure, blending public and private holdings. Read the full analysis here.

NASDAQ · BTX
Healthcare · Biotechnology
$9.01
Up+$0.02 (+0.22%)
Updated Aug 22, 2026, 7:59 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
BTX closed at $9.01 after 21 trading sessions, up 9.88% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $9.03 | $9.3725 | $8.915 | $9.01 | 306.81K |
| Aug 20, 2026 | $8.81 | $8.99 | $8.81 | $8.99 | 415.78K |
| Aug 19, 2026 | $9.09 | $9.09 | $8.81 | $8.88 | 511.72K |
| Aug 18, 2026 | $9.10 | $9.15 | $8.91 | $8.98 | 461.27K |
| Aug 17, 2026 | $9.15 | $9.35 | $9.15 | $9.25 | 638.31K |
| Aug 14, 2026 | $9.05 | $9.12 | $9.0001 | $9.11 | 587.59K |
| Aug 13, 2026 | $8.86 | $9.11 | $8.86 | $9.06 | 869.88K |
| Aug 12, 2026 | $8.76 | $8.84 | $8.70 | $8.84 | 610.91K |
| Aug 11, 2026 | $8.62 | $8.65 | $8.54 | $8.60 | 239.11K |
| Aug 10, 2026 | $8.51 | $8.64 | $8.50 | $8.58 | 317.61K |
| Aug 7, 2026 | $8.50 | $8.685 | $8.48 | $8.58 | 337.25K |
| Aug 6, 2026 | $8.42 | $8.50 | $8.37 | $8.41 | 420.19K |
| Aug 5, 2026 | $8.60 | $8.65 | $8.49 | $8.52 | 390.32K |
| Aug 4, 2026 | $8.43 | $8.61 | $8.4001 | $8.60 | 542.17K |
| Aug 3, 2026 | $7.87 | $8.25 | $7.87 | $8.25 | 432.48K |
| Jul 31, 2026 | $8.03 | $8.17 | $8.02 | $8.05 | 706.1K |
| Jul 30, 2026 | $7.74 | $7.92 | $7.74 | $7.90 | 482.88K |
| Jul 29, 2026 | $7.83 | $7.89 | $7.645 | $7.67 | 851.1K |
| Jul 28, 2026 | $7.94 | $7.97 | $7.715 | $7.87 | 679.87K |
| Jul 27, 2026 | $8.27 | $8.35 | $7.95 | $8.04 | 503.61K |
| Jul 24, 2026 | $8.30 | $8.33 | $8.171 | $8.20 | 436.24K |
The latest Smart Investors Daily articles mentioning BTX.
BTX research
Company profile and research snapshot.
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2022 | Maxim Group | Hold | — |
| Dec 29, 2021 | Cantor Fitzgerald | Overweight | — |
| Oct 6, 2021 | Maxim Group | Buy | — |
| Mar 18, 2019 | Raymond James | Outperform | — |
| Feb 21, 2019 | H.C. Wainwright | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Jul 8, 2026
BlackRock Technology and Private Equity Term Trust aims for 80% tech exposure, blending public and private holdings. Read the full analysis here.
businesswire.com · Nov 28, 2025
NEW YORK--(BUSINESS WIRE)--Today, BlackRock Resources & Commodities Strategy Trust (NYSE: BCX), BlackRock Enhanced Equity Dividend Trust (NYSE: BDJ), BlackRock Energy and Resources Trust (NYSE: BGR), BlackRock Enhanced International Dividend Trust (NYSE: BGY), BlackRock Health Sciences Trust (NYSE: BME), BlackRock Health Sciences Term Trust (NYSE: BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE: BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE: BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE: CII), BlackRock Science and Technology Trust (NYSE: BST), BlackRock Science and Technology Term Trust (NYSE: BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE: BTX), BlackRock Capital Allocation Term Trust (NYSE: BCAT), and BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT) (collectively, the “Funds”) paid the following distributions per share
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BTX.